Is BiomX Inc. (PHGE) a Buy, Sell, or Hold?
AMEX : PHGE
BiomX Inc. — Insider Trades
$0.152 USD
-$0.01 (-4.28%)
- Volume
- 133.07K
- Average Volume
- 7.68M
- Market Capitalization
- $1.54M
- P/E Ratio
- -0.01
- Dividend Yield
- 0.00%
- Price Target
- $38.00
- Year High
- $12.29
- Year Low
- $0.12
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $1.24
Insider Activity Summary (Last 12 Months)
Insiders Buying
39
Insiders Selling
21
Amount of Insider Selling
$8.22M
PHGE Insider Buying/Selling by Quarter
PHGE Insider Trading History
| Insider Name | Title | Date | Transaction | Cost | Filing Date |
|---|---|---|---|---|---|
| Yeganeh Reuven | director, 10 percent owner: | 2026-03-16 | S-Sale | 1 | 2026-03-18 |
| Yeganeh Reuven | director, 10 percent owner: | 2026-03-16 | S-Sale | 1 | 2026-03-18 |
| Yeganeh Reuven | director, 10 percent owner: | 2026-03-17 | C-Conversion | 2 | 2026-03-18 |
| Yeganeh Reuven | director, 10 percent owner: | 2026-03-16 | C-Conversion | 2 | 2026-03-18 |
| Yeganeh Reuven | director, 10 percent owner: | 2026-03-16 | C-Conversion | 2 | 2026-03-18 |
| Yeganeh Reuven | director, 10 percent owner: | 2026-03-17 | C-Conversion | 2 | 2026-03-18 |
| Yeganeh Reuven | director, 10 percent owner: | 2026-03-17 | S-Sale | 5 | 2026-03-18 |
| Yeganeh Reuven | director, 10 percent owner: | 2026-03-16 | S-Sale | 1 | 2026-03-18 |
| Yeganeh Reuven | director, 10 percent owner: | 2026-03-13 | C-Conversion | 2 | 2026-03-13 |
| Yeganeh Reuven | director, 10 percent owner: | 2026-03-11 | C-Conversion | 2 | 2026-03-13 |
| Yeganeh Reuven | director, 10 percent owner: | 2026-03-12 | C-Conversion | 2 | 2026-03-13 |
| Yeganeh Reuven | director, 10 percent owner: | 2026-03-13 | C-Conversion | 2 | 2026-03-13 |
| Yeganeh Reuven | director, 10 percent owner: | 2026-03-13 | S-Sale | 5 | 2026-03-13 |
| Bidas Liat Cohavi | director: | 2026-02-13 | 0 | 2026-03-03 | |
| Yeganeh Reuven | director, 10 percent owner: | 2026-01-02 | 2 | 2026-01-16 | |
| Yeganeh Reuven | director, 10 percent owner: | 2026-01-02 | 2 | 2026-01-16 | |
| Flynn James E | director, other: *Director by Deputization | 2025-04-21 | A-Award | 0.9306 | 2025-04-23 |
| Merril Gregory Louis | director | 2025-04-14 | A-Award | 0.538 | 2025-04-21 |
| Bassan Merav | officer: Chief Development Officer | 2025-04-14 | A-Award | 0.538 | 2025-04-21 |
| Solomon Jonathan Eitan | director, officer: Chief Executive Officer | 2025-04-14 | A-Award | 0.538 | 2025-04-21 |
| GOODMAN JESSE | director | 2025-04-14 | A-Award | 0.538 | 2025-04-21 |
| Williams Eddie | director | 2025-04-14 | A-Award | 0.538 | 2025-04-21 |
| Moses Alan Charles | director | 2025-04-14 | A-Award | 0.538 | 2025-04-21 |
| LEFF JONATHAN S | director | 2025-04-14 | A-Award | 0.538 | 2025-04-21 |
| Blum Susan | director | 2025-04-14 | A-Award | 0.538 | 2025-04-21 |
| Greig Russell | director | 2025-04-14 | A-Award | 0.538 | 2025-04-21 |
| Wolfson Marina | officer: Chief Financial Officer | 2025-04-14 | A-Award | 0.538 | 2025-04-21 |
| Flynn James E | director, other: *Director by Deputization | 2025-04-14 | A-Award | 0.538 | 2025-04-18 |
| Wolfson Marina | officer: Chief Financial Officer | 2025-04-14 | A-Award | 0.538 | 2025-04-18 |
| Wolfson Marina | officer: Chief Financial Officer | 2025-04-14 | A-Award | 0 | 2025-04-18 |
| Greig Russell | director | 2025-04-14 | A-Award | 0.538 | 2025-04-18 |
| LEFF JONATHAN S | director | 2025-04-14 | A-Award | 0.538 | 2025-04-18 |
| GOODMAN JESSE | director | 2025-04-14 | A-Award | 0.538 | 2025-04-18 |
| Bassan Merav | officer: Chief Development Officer | 2025-04-14 | A-Award | 0.538 | 2025-04-18 |
| Bassan Merav | officer: Chief Development Officer | 2025-04-14 | A-Award | 0 | 2025-04-18 |
| Williams Eddie | director | 2025-04-14 | A-Award | 0.538 | 2025-04-18 |
| Moses Alan Charles | director | 2025-04-14 | A-Award | 0.538 | 2025-04-18 |
| Solomon Jonathan Eitan | director, officer: Chief Executive Officer | 2025-04-14 | A-Award | 0.538 | 2025-04-18 |
| Solomon Jonathan Eitan | director, officer: Chief Executive Officer | 2025-04-14 | A-Award | 0 | 2025-04-18 |
| Blum Susan | director | 2025-04-14 | A-Award | 0.538 | 2025-04-18 |
| Cystic Fibrosis Foundation | 2025-02-26 | 0 | 2025-03-04 | ||
| Cystic Fibrosis Foundation | 10 percent owner | 2024-07-15 | C-Conversion | 0 | 2025-03-04 |
| Flynn James E | director, other: *Director by Deputization | 2025-02-27 | A-Award | 0 | 2025-03-03 |
| Flynn James E | director, other: *Director by Deputization | 2025-02-27 | M-Exempt | 0.9306 | 2025-03-03 |
| Flynn James E | director, other: *Director by Deputization | 2025-02-27 | M-Exempt | 0 | 2025-03-03 |
| Bassan Merav | officer: Chief Development Officer | 2024-09-16 | A-Award | 0 | 2024-09-18 |
| Solomon Jonathan Eitan | director, officer: Chief Executive Officer | 2024-09-16 | A-Award | 0 | 2024-09-18 |
| Oron Assaf | officer: Chief Business Officer | 2024-09-16 | A-Award | 0 | 2024-09-18 |
| Flynn James E | director, other: *Director by Deputization | 2024-07-15 | M-Exempt | 0 | 2024-07-17 |
| Flynn James E | director, other: *Director by Deputization | 2024-07-15 | M-Exempt | 0 | 2024-07-17 |
| Flynn James E | director, other: *Director by Deputization | 2024-07-11 | A-Award | 0.363 | 2024-07-15 |
| Blum Susan | director | 2024-07-11 | A-Award | 0.363 | 2024-07-15 |
| Greig Russell | director | 2024-07-11 | A-Award | 0.363 | 2024-07-15 |
| Bassan Merav | officer: Chief Development Officer | 2024-07-11 | A-Award | 0.363 | 2024-07-15 |
| Wolfson Marina | officer: Chief Financial Officer | 2024-07-11 | A-Award | 0.363 | 2024-07-15 |
| Solomon Jonathan Eitan | director, officer: Chief Executive Officer | 2024-07-11 | A-Award | 0.363 | 2024-07-15 |
| LEFF JONATHAN S | director | 2024-07-11 | A-Award | 0.363 | 2024-07-15 |
| GOODMAN JESSE | director | 2024-07-11 | A-Award | 0.363 | 2024-07-15 |
| Merril Gregory Louis | director | 2024-07-11 | A-Award | 0.363 | 2024-07-15 |
| Williams Eddie | director | 2024-07-11 | A-Award | 0.363 | 2024-07-15 |
| Oron Assaf | officer: Chief Business Officer | 2024-07-11 | A-Award | 0.363 | 2024-07-15 |
| Moses Alan Charles | director | 2024-07-11 | A-Award | 0.363 | 2024-07-15 |
| Flynn James E | director, 10 percent owner, other: *Director by Deputization | 2024-07-09 | A-Award | 0.2311 | 2024-07-11 |
| Flynn James E | director, 10 percent owner, other: *Director by Deputization | 2024-07-09 | A-Award | 5 | 2024-07-11 |
| OrbiMed Israel BioFund GP Limited Partnership | 10 percent owner | 2024-05-15 | X-InTheMoney | 0.244 | 2024-05-20 |
| OrbiMed Israel BioFund GP Limited Partnership | 10 percent owner | 2024-05-15 | S-Sale | 0.3812 | 2024-05-20 |
| OrbiMed Israel BioFund GP Limited Partnership | 10 percent owner | 2024-05-15 | X-InTheMoney | 0.244 | 2024-05-20 |
| Cystic Fibrosis Foundation | 10 percent owner | 2024-05-15 | X-InTheMoney | 0.001 | 2024-05-17 |
| Cystic Fibrosis Foundation | 10 percent owner | 2024-05-15 | X-InTheMoney | 0.001 | 2024-05-17 |
| Blum Susan | director: | 2024-04-11 | 0 | 2024-04-15 | |
| Cystic Fibrosis Foundation | 10 percent owner | 2024-03-16 | 0 | 2024-03-26 | |
| Cystic Fibrosis Foundation | 10 percent owner | 2024-03-16 | 0.001 | 2024-03-26 | |
| Cystic Fibrosis Foundation | 10 percent owner | 2024-03-16 | 0 | 2024-03-26 | |
| Cystic Fibrosis Foundation | 10 percent owner | 2024-03-16 | 0.2311 | 2024-03-26 | |
| LEFF JONATHAN S | director: | 2024-03-15 | 0 | 2024-03-21 | |
| Merril Gregory Louis | director: | 2024-03-15 | 0 | 2024-03-21 | |
| GOODMAN JESSE | director: | 2024-03-15 | 0 | 2024-03-21 | |
| Flynn James E | director, 10 percent owner, other: *Director by Deputization | 2024-03-15 | A-Award | 0 | 2024-03-19 |
| Flynn James E | director, 10 percent owner, other: *Director by Deputization | 2024-03-15 | A-Award | 0 | 2024-03-19 |
| Flynn James E | director, 10 percent owner, other: *Director by Deputization | 2024-03-15 | A-Award | 0 | 2024-03-19 |
| Flynn James E | director | 2024-03-15 | 0 | 2024-03-19 | |
| OrbiMed Israel BioFund GP Limited Partnership | 10 percent owner | 2024-03-15 | P-Purchase | 0.2311 | 2024-03-19 |
| OrbiMed Israel BioFund GP Limited Partnership | 10 percent owner | 2024-03-15 | P-Purchase | 0 | 2024-03-19 |
| Wolfson Marina | officer: Chief Financial Officer | 2023-12-11 | A-Award | 0.2749 | 2023-12-13 |
| Wolfson Marina | officer: Chief Financial Officer | 2023-12-11 | A-Award | 0.2749 | 2023-12-13 |
| Wolfson Marina | officer: Chief Financial Officer | 2023-12-11 | A-Award | 0.2749 | 2023-12-13 |
| Wolfson Marina | officer: Chief Financial Officer | 2023-12-11 | D-Return | 1.41 | 2023-12-13 |
| Wolfson Marina | officer: Chief Financial Officer | 2023-12-11 | D-Return | 6.21 | 2023-12-13 |
| Wolfson Marina | officer: Chief Financial Officer | 2023-12-11 | D-Return | 7.02 | 2023-12-13 |
| Bassan Merav | officer: Chief Development Officer | 2023-12-11 | A-Award | 0.2749 | 2023-12-13 |
| Bassan Merav | officer: Chief Development Officer | 2023-12-11 | A-Award | 0.2749 | 2023-12-13 |
| Bassan Merav | officer: Chief Development Officer | 2023-12-11 | D-Return | 1.41 | 2023-12-13 |
| Bassan Merav | officer: Chief Development Officer | 2023-12-11 | D-Return | 7.02 | 2023-12-13 |
| Solomon Jonathan Eitan | director, officer: Chief Executive Officer | 2023-12-11 | A-Award | 0.2749 | 2023-12-13 |
| Solomon Jonathan Eitan | director, officer: Chief Executive Officer | 2023-12-11 | A-Award | 0.2749 | 2023-12-13 |
| Solomon Jonathan Eitan | director, officer: Chief Executive Officer | 2023-12-11 | A-Award | 0.2749 | 2023-12-13 |
| Solomon Jonathan Eitan | director, officer: Chief Executive Officer | 2023-12-11 | D-Return | 1.41 | 2023-12-13 |
| Solomon Jonathan Eitan | director, officer: Chief Executive Officer | 2023-12-11 | D-Return | 7.02 | 2023-12-13 |
| Solomon Jonathan Eitan | director, officer: Chief Executive Officer | 2023-12-11 | D-Return | 6.21 | 2023-12-13 |
| Oron Assaf | officer: Chief Business Officer | 2023-12-11 | A-Award | 0.2749 | 2023-12-13 |